Cleary Gottlieb Steen & Hamilton and Slaughter and May have teamed up to advise GlaxoSmithKline (GSK) on its $210m (£128m) acquisition of some of Bristol Myers Squibb's (BMS's) Egyptian assets. The pair worked opposite DLA Piper on the deal, which sees GSK buying BMS's Egyptian mature products business
October 29, 2008 at 10:35 PM
1 minute read
The original version of this story was published on Legalweek
Cleary Gottlieb Steen & Hamilton and Slaughter and May have teamed up to advise GlaxoSmithKline (GSK) on its $210m (£128m) acquisition of some of Bristol Myers Squibb’s (BMS’s) Egyptian assets.
The pair worked opposite DLA Piper on the deal, which sees GSK buying BMS’s Egyptian mature products business.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
